Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression-Reference-Cited by-同舟云学术

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression

Published:2018-03-21 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Latonen Leena,Afyounian Ebrahim^ORCID,Jylhä Antti,Nättinen Janika,Aapola Ulla,Annala Matti^ORCID,Kivinummi Kati K.,Tammela Teuvo T. L.,Beuerman Roger W.,Uusitalo Hannu,Nykter Matti,Visakorpi Tapio

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-03573-6.pdf

Reference38 articles.

1. Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011).

2. Wong, Y. N. S., Ferraldeschi, R., Attard, G. & de Bono, J. Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat. Rev. Clin. Oncol. 11, 365–376 (2014).

3. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 18, 11–22 (2010).

4. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685–689 (2012).

5. Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239–243 (2012).

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy;International Immunopharmacology;2024-12

2. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers;Nature Cancer;2024-09-06

3. Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer;Cancer Gene Therapy;2024-08-15

4. Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction;Cell Reports Medicine;2024-08

5. Metabolic imaging across scales reveals distinct prostate cancer phenotypes;Nature Communications;2024-07-16